A medicine that is listed in the PBS to treat chronic conditions but to which only public and private hospitals with appropriate specialist facilities are allowed access because of its clinical use or other specialised features. Funding is provided under the HSD Program within s. 100 of the National Health Act 1953. CoA
Recently Added
- So You Want to Build Your Disease’s First Online Patient Registry: An Educational Guide
- Involve Australia – Guidelines for Community Involvement in Genomic Research
- Holiday Gift Guide 2023
- Interacting with Patient Communities: Areas for Pharmaceutical companies to consider
- PVI CaPPRE Enhancing Patient Engagement in Australia Report 2023